Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)
Clinical trial NCT07222579 · RECRUITING
Trial details
- NCT number
- NCT07222579
- Sponsor
- West Virginia University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-15
- Primary completion
- 2029-08-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.